KALA BIO Inc. (NASDAQ: KALA)
$7.80
-0.0200 ( -0.26% ) 18.3K
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
Market Data
Open
$7.80
Previous close
$7.82
Volume
18.3K
Market cap
$33.20M
Day range
$7.36 - $7.69
52 week range
$4.21 - $15.94
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jan 05, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |
8-k | 8K-related | 17 | Dec 22, 2023 |
8-k | 8K-related | 13 | Nov 13, 2023 |
10-q | Quarterly Reports | 82 | Nov 13, 2023 |
8-k | 8K-related | 14 | Aug 04, 2023 |
10-q | Quarterly Reports | 92 | Aug 04, 2023 |
8-k | 8K-related | 14 | Aug 02, 2023 |